UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Total Assets (Quarterly): 16.75B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.75B |
| June 30, 2024 | 16.75B |
| December 31, 2023 | 17.18B |
| June 30, 2023 | 16.72B |
| June 30, 2023 | 16.72B |
| December 31, 2022 | 17.02B |
| June 30, 2022 | 17.04B |
| June 30, 2022 | 17.04B |
| December 31, 2021 | 16.09B |
| June 30, 2021 | 15.52B |
| June 30, 2021 | 15.52B |
| December 31, 2020 | 16.38B |
| June 30, 2020 | 14.86B |
| June 30, 2020 | 14.86B |
| December 31, 2019 | 12.41B |
| June 30, 2019 | 11.96B |
| June 30, 2019 | 11.96B |
| December 31, 2018 | 12.03B |
| June 30, 2018 | 11.79B |
| June 30, 2018 | 11.79B |
| December 31, 2017 | 11.90B |
| June 30, 2017 | 11.22B |
| Date | Value |
|---|---|
| June 30, 2017 | 11.22B |
| December 31, 2016 | 10.80B |
| June 30, 2016 | 11.34B |
| June 30, 2016 | 11.34B |
| December 31, 2015 | 11.98B |
| June 30, 2015 | 11.84B |
| June 30, 2015 | 11.84B |
| December 31, 2014 | 12.34B |
| June 30, 2014 | 13.27B |
| June 30, 2014 | 13.27B |
| December 31, 2013 | 13.48B |
| June 30, 2013 | 12.46B |
| June 30, 2013 | 12.46B |
| December 31, 2012 | 12.37B |
| June 30, 2012 | 11.67B |
| June 30, 2012 | 11.67B |
| December 31, 2011 | 11.89B |
| June 30, 2011 | 12.32B |
| December 31, 2010 | 11.93B |
| June 30, 2010 | 12.18B |
| December 31, 2009 | 13.04B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.41B
Minimum
Dec 2019
17.18B
Maximum
Dec 2023
16.06B
Average
16.72B
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Galapagos NV | 4.660B |
| Mithra Pharmaceuticals SA | 407.25M |
| Nyxoah SA | 159.45M |
| Celyad Oncology SA | 13.23M |
| MDxHealth SA | 157.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.156B |
| Shareholders Equity (Quarterly) | 9.597B |
| Debt to Equity Ratio | 0.3178 |
| Current Ratio | 1.187 |
| Net Debt Paydown Yield | -0.11% |